One Assessment, Many Futures: Evolution of EU JCA

Описание: 🔬 One Assessment, Many Futures — what does EU Joint Clinical Assessment really mean for patient access across Europe?

As the first EU JCA reports take shape, questions around evidence requirements, payer adoption, and organizational readiness are top of mind for pharma, payers, and patient advocates alike.

Michael Scholler (Astellas) and Dmitry Goldenberg (Simon-Kucher) sat down ahead of the European Access Forum 2026 to unpack the key challenges and opportunities of JCA implementation and preview what senior access leaders will be discussing in Lisbon this October.

📍 EU Access Forum 2026 | 7–9 October | Pestana Palace, Lisbon
🎥 Watch the preview interview and register: https://theaccessforum.org/eu26lisbon

#EUJCA #HTA #MarketAccess #PatientAccess #EUHTA #Pharma #LifeSciences #EUAccessForum #PricingAndReimbursement #HealthcarePolicy